"Gram-Negative Bacteria" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method.
| Descriptor ID |
D006090
|
| MeSH Number(s) |
B03.440
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Gram-Negative Bacteria".
Below are MeSH descriptors whose meaning is more specific than "Gram-Negative Bacteria".
This graph shows the total number of publications written about "Gram-Negative Bacteria" by people in this website by year, and whether "Gram-Negative Bacteria" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 3 | 2 | 5 |
| 1997 | 2 | 0 | 2 |
| 1998 | 0 | 2 | 2 |
| 1999 | 1 | 0 | 1 |
| 2000 | 2 | 0 | 2 |
| 2002 | 3 | 0 | 3 |
| 2003 | 1 | 1 | 2 |
| 2004 | 2 | 1 | 3 |
| 2005 | 2 | 0 | 2 |
| 2006 | 1 | 1 | 2 |
| 2007 | 4 | 2 | 6 |
| 2008 | 5 | 1 | 6 |
| 2009 | 0 | 2 | 2 |
| 2010 | 2 | 2 | 4 |
| 2011 | 2 | 1 | 3 |
| 2012 | 3 | 0 | 3 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 2 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 2 | 2 |
| 2017 | 2 | 1 | 3 |
| 2018 | 0 | 1 | 1 |
| 2019 | 2 | 1 | 3 |
| 2020 | 4 | 0 | 4 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 1 | 1 |
| 2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gram-Negative Bacteria" by people in Profiles.
-
A randomized non-inferiority study comparing imipenem/cilastatin/relebactam with standard-of-care Gram-negative coverage in cancer patients with febrile neutropenia. J Antimicrob Chemother. 2024 Oct 01; 79(10):2543-2553.
-
A Gram-negative-selective antibiotic that spares the gut microbiome. Nature. 2024 Jun; 630(8016):429-436.
-
The emergence of cefiderocol resistance in Pseudomonas aeruginosa from a heteroresistant isolate during prolonged therapy. Antimicrob Agents Chemother. 2024 Jan 10; 68(1):e0100923.
-
Casting Zinc Oxide Nanoparticles Using Fagonia Blend Microbial Arrest. Appl Biochem Biotechnol. 2023 Jan; 195(1):264-282.
-
Antimicrobial Treatment Options for Difficult-to-Treat Resistant Gram-Negative Bacteria Causing Cystitis, Pyelonephritis, and Prostatitis: A Narrative Review. Drugs. 2022 Mar; 82(4):407-438.
-
In vitro activity of imipenem/releactam and comparator agents against clinical bacterial isolates from patients with cancer. J Glob Antimicrob Resist. 2022 06; 29:1-6.
-
Pattern of clinical drug resistance and occurrence of Gram negative bacterial neonatal sepsis at a tertiary care hospital. Pak J Pharm Sci. 2021 Sep; 34(5(Supplementary)):1873-1878.
-
New ?-Lactam-?-Lactamase Inhibitor Combinations. Clin Microbiol Rev. 2020 12 16; 34(1).
-
Topoisomerase Inhibitors Addressing Fluoroquinolone Resistance in Gram-Negative Bacteria. J Med Chem. 2020 07 23; 63(14):7773-7816.
-
Activity of Cefiderocol and Comparators against Isolates from Cancer Patients. Antimicrob Agents Chemother. 2020 04 21; 64(5).